Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fraction

Future Cardiology

Volumn 13, Issue 5, 2017, Pages 451-463

  Carbone, Salvatore ^a,b   Popovic, Dejana ^c   Lavie, Carl J ^d   Arena, Ross ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Body composition; cardiorespiratory fitness; fat mass; heart failure with preserved ejection fraction; lean mass; skeletal muscle mass

Indexed keywords

BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; DIABETES MELLITUS; FAT MASS; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FUNCTION; HUMAN; LEAN BODY WEIGHT; LEAN TISSUE; METABOLIC DISORDER; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVIEW;

EID: 85029663418     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca-2017-0023     Document Type: Review

References (103)

1. WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Heal. Organ. Tech. Rep.Ser. 894(i-xii), 1-253 (2000).
2. Breland JY, Phibbs CS, Hoggatt KJ, et al. The obesity epidemic in the Veterans Health Administration: Prevalence among keypopulations of women and men veterans. J. Gen. Intern. Med. 32(Suppl. 1), 11-17 (2017).
3. Rutter H, Bes-Rastrollo M, de Henauw S, et al. Balancing upstream and downstream measures to tackle the obesity epidemic: A positionstatement from the European association for the study of obesity. Obes. Facts. 10(1), 61-63 (2017).
4. Cuschieri S, Mamo J. Getting to grips with the obesity epidemic in Europe. SAGE Open Med. 4, 2050312116670406 (2016).
5. Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA 315(21), 2284 (2016).
6. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347(5), 305-313 (2002).
7. Baena-Déz JM, Byram AO, Grau M, et al. Obesity is an independent risk factor for heart failure: Zona Franca Cohort study. Clin.Cardiol. 33(12), 760-764 (2010).
8. Padwal R, McAlister FA, McMurray JJ, et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction:a meta-analysis of individual patient data. Int. J. Obes. (Lond.) 38(8), 1110-1114 (2013)
9. Sharma A, Lavie CJ, Borer JS, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality andhospitalization in patients with chronic heart failure. Am. J. Cardiol. 115(10), 1428-1434 (2015).
10. Carbone S, Lavie CJ, Arena R. Obesity and heart failure: Focus on the obesity paradox. Mayo Clin. Proc. 92(2), 266-279 (2017)
11. Lavie CJ, De Schutter A, Parto P, et al. Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated.Prog. Cardiovasc. Dis. 58(5), 537-547 (2016).
12. Arena R, Lavie CJ. The obesity paradox and outcome in heart failure: Is excess bodyweight truly protective Future Cardiol. 6(1), 1-6(2010).
13. Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage evenhaving a normal BMI. Obesity (Silver Spring). 19(7), 1439-1444 (2011).
14. Abbate A, Arena R, Abouzaki N, et al. Heart failure with preserved ejection fraction: Refocusing on diastole. Int. J.Cardiol. 179, 430-440 (2015)
15. Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 11(9), 507-515 (2014).
16. Sharma K, Kass DA. Heart failure with preserved ejection fraction: Mechanisms, clinical features, and therapies. Circ. Res. 115(1), 79-96(2014).
17. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics-2017 Update: A report from the American HeartAssociation. Circulation 135(10), e146-e603 (2017).
18. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure withpreserved ejection fraction. N. Engl. J. Med. 355(3), 251-259 (2006).
19. Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: Epidemiology, pathophysiology, clinicalmanifestations, and management. Transl. Res. 164(4), 345-356 (2014).
20. Kitzman DW, Shah SJ. The HFpEF obesity phenotype: The elephant in the room. J Am. Coll. Cardiol. 68(2), 200-203 (2016).
21. Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: A multiorganroadmap. Circulation 134(1), 73-90 (2016).
22. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heartfailure patients with preserved ejection fraction. J. Am. Coll. Cardiol. 58(3), 265-274 (2011)
23. Dhakal BP, Malhotra R, Murphy RM, et al. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: The roleof abnormal peripheral oxygen extraction. Circ. Heart Fail. 8(2), 286-294 (2015).
24. Malhotra R, Bakken K, D'Elia E, Lewis GD. Cardiopulmonary exercise testing in heart failure. J. Am. Coll. Cardiol. HF. 4(8), 607-616(2016).
25. Krachler B, Savonen K, Komulainen P, Hassinen M, Lakka TA, Rauramaa R. VO2max/kg is expected to be lower in obeseindividuals! Int. J. Cardiol. 189, 234 (2015).
26. Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption andquality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinicaltrial. JAMA 315(1), 36-46 (2016)
27. deJong AT, Gallagher MJ, Sandberg KR, et al. Peak oxygen consumption and the minute ventilation/carbon dioxide production relationslope in morbidly obese men and women: Influence of subject effort and body mass index. Prev. Cardiol. 11(2), 100-105 (2008).
28. Myers J, Arena R, Cahalin LP, Labate V, Guazzi M. Cardiopulmonary exercise testing in heart failure. Curr. Probl. Cardiol. 40(8), 322-372 (2015).
29. Guazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 Focused Update: Clinical recommendations for cardiopulmonaryexercise testing data assessment in specific patient populations. Circulation 133(24), e694-e711 (2016).
30. Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonaryexercise testing data assessment in specific patient populations. Eur. Heart J. 33(23), 2917-2927 (2012).
31. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events inhealthy men and women: A meta-analysis. JAMA 301(19), 2024-2035 (2009).
32. Balady GJ, Arena R, Sietsema K, et al. Clinician's Guide to cardiopulmonary exercise testing in adults: A scientific statement from theAmerican Heart Association. Circulation 122(2), 191-225 (2010).
33. Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: How do we differentiate the cause of Dyspnea Circulation 110(4), e27-e31 (2004).
34. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timingof cardiac transplantation in ambulatory patients with heart failure. Circulation 83(3), 778-786 (1991).
35. Haykowsky MJ, Tomczak CR, Scott JM, Paterson DI, Kitzman DW. Determinants of exercise intolerance in patients with heart failureand reduced or preserved ejection fraction. J. Appl. Physiol. 119(6), 739-744 (2015).
36. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults: A scientific statement from theAmerican Heart Association. Circulation 122(2), 191-225 (2010).
37. Guazzi M, Adams V, Conraads V, et al. Clinical recommendations for cardiopulmonary exercise testing data assessment in specificpatient populations. Circulation 126(18), 2261-2274 (2012).
38. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygenconsumption in chronic heart failure. J. Am. Coll. Cardiol. 36(7), 2126-2131 (2000).
39. Krachler B, Savonen K, Komulainen P, Hassinen M, Lakka TA, Rauramaa R. Cardiopulmonary fitness is a function of lean mass, nottotal body weight : The DR's EXTRA study. Eur. J. Prev. Cardiol. 22(9), 1171-1179 (2015).
40. Arena R, Myers J, Abella J, et al. Determining the preferred percent-predicted equation for peak oxygen consumption in patients withheart failure. Circ. Heart Fail. 2(2), 113-120 (2009).
41. Kaminsky LA, Arena R, Myers J. Reference standards for cardiorespiratory fitness measured with cardiopulmonary exercise testing: Datafrom the fitness registry and the importance of exercise national database. Mayo Clin. Proc. 90(11), 1515-1523 (2015).
42. Kaminsky LA, Imboden MT, Arena R, Myers J. Reference standards for cardiorespiratory fitness measured with cardiopulmonaryexercise testing using cycle ergometry: Data from the fitness registry and the importance of exercise national database (FRIEND) registry.Mayo Clin. Proc. 92(2), 228-233 (2017).
43. Cahalin LP, Chase P, Arena R, et al. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients withheart failure. Heart Fail. Rev. 18(1), 79-94 (2013).
44. Heymsfield S, Lohman T, Wang Z-M, Going S. Human Body Composition (2nd Edition). Human Kinetics IL, USA (2005).
45. Gómez-ambrosi J, Silva C, Galofré JC, et al. Body adiposity and Type 2 diabetes : Increased risk with a high body fat percentage evenhaving a normal BMI. Obesity 19(7), 1439-1444 (2009).
46. Burkhauser RV, Cawley J. Beyond BMI: The value of more accurate measures of fatness and obesity in social science research. J. HealthEcon. 27(2), 519-529 (2008).
47. Rothman KJ. BMI-related errors in the measurement of obesity. Int. J. Obes. (Lond.) 32(Suppl. 3), S56-S59 (2008).
48. Wang ZM, Pierson RN, Heymsfield SB. The five-level model: A new approach to organizing body-composition research. Am. J. Clin.Nutr. 56(1), 19-28 (1992).
49. Heymsfield SB, Ebbeling CB, Zheng J, et al. Multi-component molecular-level body composition reference methods: Evolving conceptsand future directions. Obes. Rev. 16(4), 282-294 (2015)
50. Prado CMM, Heymsfield SB. Lean tissue imaging: A new era for nutritional assessment and intervention. JPEN J. Parenter. EnteralNutr. 38(8), 940-953 (2014).
51. Carbone S, Buckley L, Trankle C, et al. Obesity and heart failure: Can nutritional status explain the paradoxical relationship ECCardiol. 2(2), 94-98 (2015).
52. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J. CachexiaSarcopenia Muscle. 1(2), 129-133 (2010).
53. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the Europeanworking group on Sarcopenia in older people. Age Ageing 39(4), 412-423 (2010).
54. Bekfani T, Pellicori P, Morris DA, et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on musclestrength, exercise capacity and quality of life. Int. J. Cardiol. 222, 41-46 (2016).
55. Prado CMM, Wells JCK, Smith SR, Stephan BCM, Siervo M. Sarcopenic obesity: A critical appraisal of the current evidence. Clin.Nutr. 31(5), 583-601 (2012).
56. Wannamethee SG, Atkins JL. Conference on "Nutrition and age-related muscle loss, sarcopenia and cachexia" Symposium 4: Sarcopeniaand cachexia and social, clinical and public health demensions Muscle loss and obesity: The health implications of sarcopenia andsarcopenic obesity. Proc. Nutr. Soc. 74(4), 405-418 (2015).
57. Ali S, Garcia JM. Sarcopenia, cachexia and aging: Diagnosis, mechanisms and therapeutic options-a mini-review. Gerontology 60(4), 294-305 (2014).
58. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: An approach fordeveloping guidelines based on body mass index. Am. J. Clin. Nutr. 72(3), 694-701 (2000).
59. Newman AB, Kupelian V, Visser M, et al. Sarcopenia: Alternative definitions and associations with lower extremity function. J. Am.Geriatr. Soc. 51(11), 1602-1609 (2003).
60. Delmonico MJ, Harris ATB, Lee J, et al. Alternative definitions of Sarcopenia, lower extremity performance, and functional impairmentwith aging in older men and women. J. Am. Geriatr. Soc. 55, 769-774 (2007).
61. Upadhya B, Haykowsky MJ, Eggebeen J, Kitzman DW. Exercise intolerance in heart failure with preserved ejection fraction: More thana heart problem. J. Geriatr. Cardiol. 12(3), 294-304 (2015).
62. Forbes GB, Welle SL. Lean body mass in obesity. Int. J. Obes. 7(2), 99-107 (1983).
63. Alpert MA, Alexander JK. Hemodynamics alterations with obesity in man. In: The Heart and Lung in Obesity. Wiley-Blackwell, NewYork, NY, USA.
64. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence andprognosis in heart failure. JACC Heart Fail. 1(2), 93-102 (2013).
65. Lavie CJ, Sharma A, Alpert MA, et al. Update on obesity and obesity paradox in heart failure. Prog. Cardiovasc. Dis. 58(4), 393-400(2016).
66. Braunwald E. Heart Failure. J. Am. Coll. Cardiol. HF. 1(1), 1-20 (2013).
67. Cicoira M, Zanolla L, Franceschini L, et al. Skeletal muscle mass independently predicts peak oxygen consumption and ventilatoryresponse during exercise in noncachectic patients with chronic heart failure. J. Am. Coll. Cardiol. 37(8), 2080-2085 (2001).
68. Lavie CJ, Forman DE, Arena R. Bulking up skeletal muscle to improve heart failure prognosis. JACC Heart Fail. 4(4), 274-276 (2016).
69. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygenconsumption in chronic heart failure. J. Am. Coll. Cardiol. 36(7), 2126-2131 (2000).
70. Kitzman DW, Nicklas B, Kraus WE, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure andpreserved ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 306(9), H1364-H1370 (2014).
71. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 85(5), 1751-1759 (1992).
72. Molina AJA, Bharadwaj MS, Van Horn C, et al. Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression arereduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance. J. Am. Coll. Cardiol.HF. 4(8), 636-645 (2016).
73. Haykowsky MJ, Brubaker PH, Morgan TM, Kritchevsky S, Eggebeen J, Kitzman DW. Impaired aerobic capacity and physicalfunctional performance in older heart failure patients with preserved ejection fraction: Role of lean body mass. J. Gerontol. A Biol. Sci.Med. Sci. 68(8), 968-975 (2013).
74. Haykowsky MJ, Kouba EJ, Brubaker PH, Nicklas BJ, Eggebeen J, Kitzman DW. Skeletal muscle composition and its relation to exerciseintolerance in older patients with heart failure and preserved ejection fraction. Am. J. Cardiol. 113(7), 1211-1216 (2014).
75. Ballak DB, Stienstra R, Tack CJ, Dinarello CA, van Diepen JA. Cytokine IL-1 family members in the pathogenesis and treatment ofmetabolic disease: Focus on adipose tissue inflammation and insulin resistance. Cytokine 75(2), 280-290 (2015).
76. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int. J. Obes. Relat.Metab. Disord. 27(8), 875-888 (2003).
77. Nagareddy PR, Kraakman M, Masters SL, et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. CellMetab. 19(5), 821-835 (2014).
78. Carbone S, Shah K, Van Tassell B, et al. Obesity and diastolic heart failure: Is inflammation the link Transl. Med. 3, e124 (2013).
79. Aguirre LE, Jan IZ, Fowler K, Waters DL, Villareal DT, Armamento-Villareal R. Testosterone and adipokines are determinants ofphysical performance, strength, and aerobic fitness in frail, obese, older adults. Int. J. Endocrinol. 2014, 507395 (2014).
80. Conraads VM, Van Craenenbroeck EM, De Maeyer C, Van Berendoncks AM, Beckers PJ, Vrints CJ. Unraveling new mechanisms ofexercise intolerance in chronic heart failure: Role of exercise training. Heart Fail. Rev. 18(1), 65-77 (2013).
81. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116(7), 1784-1792 (2006).
82. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.Circulation 112(12), 1756-1762 (2005).
83. Tamura T, Furukawa Y, Taniguchi R, et al. Serum adiponectin level as an independent predictor of mortality in patients with congestiveheart failure. Circ. J. 71(5), 623-630 (2007).
84. Van Berendoncks AM, Garnier A, Beckers P, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild tomoderate chronic heart failure. Circ. Heart Fail. 3(2), 185-194 (2010).
85. Takano H, Obata J, Kodama Y, et al. Adiponectin is released from the heart in patients with heart failure. Int. J. Cardiol. 132(2), 221-226 (2009).
86. Tsukamoto O, Fujita M, Kato M, et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patientswith chronic heart failure. J. Am. Coll. Cardiol. 53(22), 2070-2077 (2009).
87. George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92(10), 1420-1424 (2006).
88. Frankel DS, Vasan RS, D'Agostino RB, et al. Resistin, adiponectin, and risk of heart failure. J. Am. Coll. Cardiol. 53(9), 754-762 (2009).
89. Lieb W, Sullivan LM, Harris TB, et al. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality inelderly individuals. Diabetes Care 32(4), 612-616 (2009).
90. Carbone S, Canada JM, Buckley LF, et al. Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction. J.Am. Coll. Cardiol. 68(22), 2487-2488 (2016).
91. Wolk R, Johnson BD, Somers VK. Leptin and the ventilatory response to exercise in heart failure. J. Am. Coll. Cardiol. 42(9), 1644-1649 (2003).
92. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J.Med. 360(15), 1509-1517 (2009).
93. Celi FS. Brown adipose tissue-when it pays to be inefficient. N. Engl. J. Med. 360(15), 1553-1556 (2009).
94. Thoonen R, Hindle AG, Scherrer-Crosbie M. Brown adipose tissue: The heat is on the heart. Am. J. Physiol. 310(11), H1592-H1605(2016).
95. Valero-Muñoz M, Li S, Wilson RM, et al. Heart failure with preserved ejection fraction induces beiging in adipose tissue. Circ. HeartFail. 9(1), e002724 (2016).
96. Bundgaard H, Axelsson A, Hartvig Thomsen J, et al. The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heartfailure: The BEAT-HF trial. Eur. J. Heart Fail. 19(4), 566-575 (2017).
97. Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption andquality of life in obese older patients with heart failure with preserved ejection fraction A randomized clinical trial. JAMA 1045(1), 36-46 (2016).
98. Oda K, Miyatake N, Sakano N, et al. Relationship between peak oxygen uptake and regional body composition in Japanese subjects. J.Sport Heal. Sci. 3(3), 233-238 (2014).
99. Look AHEAD Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in Type 2 diabetes. N.Engl. J. Med. 369(2), 145-154 (2013).
100. Look AHEAD Research Group, Gregg E, Jakicic J, et al. Association of the magnitude of weight loss and changes in physical fitness withlong-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: A post-hoc analysis of the Look AHEADrandomised clinical trial. Lancet Diabetes Endocrinol. 4(11), 913-921 (2016).
101. Belalcazar LM, Ballantyne CM. Looking back at look AHEAD through the lens of recent diabetes outcome trials. Circulation. 135(8), 720-723 (2017).
102. O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure. JAMA 301(14), 1439 (2009).
103. Carbone S, Canada JM, Buckley LF, et al. Dietary fat, sugar consumption and cardiorespiratory fitness in patients with heart failure withpreserved ejection fraction. J. Am. Coll. Cardiol. Basic Trans. Science (2017) (In Press).